SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-124593
Filing Date
2022-12-05
Accepted
2022-12-05 16:45:39
Documents
16
Period of Report
2022-12-05
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2231838d1_8k.htm   iXBRL 8-K 29981
2 EXHIBIT 3.1 tm2231838d1_ex3-1.htm EX-3.1 11372
3 EXHIBIT 10.1 tm2231838d1_ex10-1.htm EX-10.1 5891
4 EXHIBIT 99.1 tm2231838d1_ex99-1.htm EX-99.1 13220
8 GRAPHIC tm2231838d1_ex99-1img01.jpg GRAPHIC 15443
  Complete submission text file 0001104659-22-124593.txt   270456

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ckpt-20221205.xsd EX-101.SCH 3045
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ckpt-20221205_lab.xml EX-101.LAB 34476
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ckpt-20221205_pre.xml EX-101.PRE 22603
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2231838d1_8k_htm.xml XML 3829
Mailing Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453
Business Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453 781-652-4500
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38128 | Film No.: 221445587
SIC: 2834 Pharmaceutical Preparations